PLA2G6 and neurodegeneration with brain iron accumulation 2A: Decrease cellular abnormalities in preclinical models (flies and cells without PLA2G6). However, not recommended for the treatment of PLAN in humans due to potential risks and lack of data supporting its clinical benefit in patients [24].